<?xml version='1.0' encoding='utf-8'?>
<document id="31267026"><sentence text="Oral Administration of Caffeine Exacerbates Cisplatin-Induced Hearing Loss."><entity charOffset="23-31" id="DDI-PubMed.31267026.s1.e0" text="Caffeine" /></sentence><sentence text="Adenosine A1 receptors (A1AR) are well characterized for their role in cytoprotection"><entity charOffset="0-9" id="DDI-PubMed.31267026.s2.e0" text="Adenosine" /></sentence><sentence text=" Previous studies have demonstrated the presence of these receptors in the cochlea where their activation were shown to suppress cisplatin-induced inflammatory response and the resulting ototoxicity"><entity charOffset="129-138" id="DDI-PubMed.31267026.s3.e0" text="cisplatin" /></sentence><sentence text=" Inhibition of A1AR by caffeine, a widely consumed psychoactive substance, could antagonize the endogenous protective role of these receptors in cochlea and potentiate cisplatin-induced hearing loss"><entity charOffset="23-31" id="DDI-PubMed.31267026.s4.e0" text="caffeine" /><entity charOffset="168-177" id="DDI-PubMed.31267026.s4.e1" text="cisplatin" /><pair ddi="false" e1="DDI-PubMed.31267026.s4.e0" e2="DDI-PubMed.31267026.s4.e0" /><pair ddi="false" e1="DDI-PubMed.31267026.s4.e0" e2="DDI-PubMed.31267026.s4.e1" /></sentence><sentence text=" This hypothesis was tested in a rat model of cisplatin ototoxicity following oral administration of caffeine"><entity charOffset="46-55" id="DDI-PubMed.31267026.s5.e0" text="cisplatin" /><entity charOffset="101-109" id="DDI-PubMed.31267026.s5.e1" text="caffeine" /><pair ddi="false" e1="DDI-PubMed.31267026.s5.e0" e2="DDI-PubMed.31267026.s5.e0" /><pair ddi="false" e1="DDI-PubMed.31267026.s5.e0" e2="DDI-PubMed.31267026.s5.e1" /></sentence><sentence text=" We report here that single-dose administration of caffeine exacerbates cisplatin-induced hearing loss without increasing the damage to outer hair cells (OHCs), but increased synaptopathy and inflammation in the cochlea"><entity charOffset="51-59" id="DDI-PubMed.31267026.s6.e0" text="caffeine" /><entity charOffset="72-81" id="DDI-PubMed.31267026.s6.e1" text="cisplatin" /><pair ddi="false" e1="DDI-PubMed.31267026.s6.e0" e2="DDI-PubMed.31267026.s6.e0" /><pair ddi="false" e1="DDI-PubMed.31267026.s6.e0" e2="DDI-PubMed.31267026.s6.e1" /></sentence><sentence text=" These effects of caffeine were mediated by its blockade of A1AR, as co-administration of R-PIA, an A1AR agonist, reversed the detrimental actions of caffeine and cisplatin on hearing loss"><entity charOffset="18-26" id="DDI-PubMed.31267026.s7.e0" text="caffeine" /><entity charOffset="150-158" id="DDI-PubMed.31267026.s7.e1" text="caffeine" /><entity charOffset="163-172" id="DDI-PubMed.31267026.s7.e2" text="cisplatin" /><pair ddi="false" e1="DDI-PubMed.31267026.s7.e0" e2="DDI-PubMed.31267026.s7.e0" /><pair ddi="false" e1="DDI-PubMed.31267026.s7.e0" e2="DDI-PubMed.31267026.s7.e1" /><pair ddi="false" e1="DDI-PubMed.31267026.s7.e0" e2="DDI-PubMed.31267026.s7.e2" /><pair ddi="false" e1="DDI-PubMed.31267026.s7.e1" e2="DDI-PubMed.31267026.s7.e1" /><pair ddi="false" e1="DDI-PubMed.31267026.s7.e1" e2="DDI-PubMed.31267026.s7.e2" /></sentence><sentence text=" Multiple doses of caffeine exacerbated cisplatin ototoxicity which was associated with damage to OHCs and cochlear synaptopathy"><entity charOffset="19-27" id="DDI-PubMed.31267026.s8.e0" text="caffeine" /><entity charOffset="40-49" id="DDI-PubMed.31267026.s8.e1" text="cisplatin" /><pair ddi="false" e1="DDI-PubMed.31267026.s8.e0" e2="DDI-PubMed.31267026.s8.e0" /><pair ddi="false" e1="DDI-PubMed.31267026.s8.e0" e2="DDI-PubMed.31267026.s8.e1" /></sentence><sentence text=" These findings highlight a possible drug-drug interaction between caffeine and cisplatin for ototoxicity andÂ suggest that caffeine consumption should be cautioned in cancer patients treated with a chemotherapeutic regimen containing cisplatin"><entity charOffset="67-75" id="DDI-PubMed.31267026.s9.e0" text="caffeine" /><entity charOffset="80-89" id="DDI-PubMed.31267026.s9.e1" text="cisplatin" /><entity charOffset="123-131" id="DDI-PubMed.31267026.s9.e2" text="caffeine" /><entity charOffset="234-243" id="DDI-PubMed.31267026.s9.e3" text="cisplatin" /><pair ddi="false" e1="DDI-PubMed.31267026.s9.e0" e2="DDI-PubMed.31267026.s9.e0" /><pair ddi="false" e1="DDI-PubMed.31267026.s9.e0" e2="DDI-PubMed.31267026.s9.e1" /><pair ddi="false" e1="DDI-PubMed.31267026.s9.e0" e2="DDI-PubMed.31267026.s9.e2" /><pair ddi="false" e1="DDI-PubMed.31267026.s9.e0" e2="DDI-PubMed.31267026.s9.e3" /><pair ddi="false" e1="DDI-PubMed.31267026.s9.e1" e2="DDI-PubMed.31267026.s9.e1" /><pair ddi="false" e1="DDI-PubMed.31267026.s9.e1" e2="DDI-PubMed.31267026.s9.e2" /><pair ddi="false" e1="DDI-PubMed.31267026.s9.e1" e2="DDI-PubMed.31267026.s9.e3" /><pair ddi="false" e1="DDI-PubMed.31267026.s9.e2" e2="DDI-PubMed.31267026.s9.e2" /><pair ddi="false" e1="DDI-PubMed.31267026.s9.e2" e2="DDI-PubMed.31267026.s9.e3" /></sentence><sentence text="" /></document>